Stay informed with the latest litigation news. Explore now

IP Verse

Janssen Sciences Ireland Uc patent opposition analysis

Latest patents of Janssen Sciences Ireland Uc New

Explore the latest patents granted to Janssen Sciences Ireland Uc, showcasing their recent innovations and technological advancements.

Last updated on: Aug 31, 2025
Patent NumberGrant DateTitleLegal Status

Get instant update for new patents of Janssen Sciences Ireland Uc

EP2040671
Jan 24, 2018Aqueous Suspensions Of Tmc278Opposition Rejected
EP2767539
Jul 12, 2017Pseudopolymorphic Forms Of A Hiv Protease InhibitorOpposition Rejected

Latest oppositions filed by Janssen Sciences Ireland Uc

Explore patent oppositions filed by Janssen Sciences Ireland Uc against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2397155
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)PathwayDANA FARBER CANCER INSTITUTESep 13, 2018

Latest patents of Janssen Sciences Ireland Uc opposed by its competitors

Explore Janssen Sciences Ireland Uc's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2040671
Jan 24, 2018Aqueous Suspensions Of Tmc2781
EP2767539
Jul 12, 2017Pseudopolymorphic Forms Of A Hiv Protease Inhibitor1

Top competitors of Janssen Sciences Ireland Uc

Top competitors of Janssen Sciences Ireland Uc based on patent oppositions.